In contrast, we focused on the potential involvement of CD73 in modulating NAD+ levels in cancer cells to resolve an ongoing debate in the field with regard to a role for CD73 in metabolizing extracellular NAD+ and NMN to NR that then could contribute to intracellular levels of NAD+59. The gene discussed is NT5E; the disease is cancer.